CIRC(01763),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01763 CIRC

Closed 12-23 16:08:07

20.500

-0.300

-1.44%

High20.960	Low20.500	Vol136.00K
Open20.720	D1 Closing20.800	Amplitude2.21%
Mkt Cap6.56B	Tradable Cap1.64B	Total Shares320.00M
T/O2.81M	T/O Rate0.17%	Tradable Shares79.97M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01763","market":"HK","secType":"STK","nameCN":"CIRC","latestPrice":20.5,"timestamp":1766477287402,"preClose":20.8,"halted":0,"volume":136000,"delay":0,"floatShares":79968800,"shares":320000000,"eps":1.408775897802044,"marketStatus":"Closed","change":-0.3,"latestTime":"12-23 16:08:07","open":20.72,"high":20.96,"low":20.5,"amount":2811292,"amplitude":0.022115,"askPrice":20.6,"askSize":6600,"bidPrice":20.5,"bidSize":1600,"shortable":0,"etf":0,"ttmEps":1.4693961853096273,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":5,"adr":0,"listingDate":1530806400000,"exchange":"SEHK","adjPreClose":20.8,"dividendRate":0.020788,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":1.096774,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01763","defaultTab":"news","newsList":[{"id":"2592164449","title":"China Isotope & Radiation's Unit Gets China Nod for Trial of Tumor Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2592164449","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592164449?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:46","pubTimestamp":1766148383,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation (HKG:1763) said the clinical trial application for Borofalan (10B) for Injection has been approved by China's National Medical Products Administration, a Friday Hong Kong bou","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"1109607811","title":"CIRC (01763) Subsidiary Secures Clinical Trial Approval for BNCT Boron Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1109607811","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109607811?lang=en_us&edition=fundamental","pubTime":"2025-12-19 20:08","pubTimestamp":1766146120,"startTime":"0","endTime":"0","summary":"CIRC (01763) announced that its subsidiary, Shenzhen Zhonghe Haidewei Biotechnology Co., Ltd. (Haidewei), has received approval from the Center for Drug Evaluation (CDE) of China's National Medical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2592122169","title":"China Isotope & Radiation Corp - Zhonghe Headway Obtains Clinical Trial Approval for Bnct Boron Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2592122169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592122169?lang=en_us&edition=fundamental","pubTime":"2025-12-19 19:59","pubTimestamp":1766145586,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0EA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2592169995","title":"Zhonghe Headway Wins Clinical Trial Approval for BNCT Boron Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2592169995","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592169995?lang=en_us&edition=fundamental","pubTime":"2025-12-19 19:59","pubTimestamp":1766145569,"startTime":"0","endTime":"0","summary":"Zhonghe Headway, a Subsidiary of China Isotope & Radiation Corporation, Secures Clinical Trial Approval for BNCT Boron Drug. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Isotope & Radiation Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDLbPPGml:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2592590298","title":"China Isotope & Radiation Corporation Announces Date for Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592590298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592590298?lang=en_us&edition=fundamental","pubTime":"2025-12-18 22:42","pubTimestamp":1766068967,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation Corporation has announced that it will hold its first extraordinary general meeting of 2026 on January 9, 2026, in Haidian District, Beijing, China. At the meeting, shareholders will consider and vote on the approval of the Renewed Products and Services Supply Framework Agreement and the transactions contemplated under it, including the proposed annual caps. Additionally, shareholders will consider and approve the Renewed Products and Services Purchase Framework Agreement and the transactions contemplated under it, also including the proposed annual caps.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Isotope & Radiation Corporation published the original content used to generate this news brief via IIS,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL57GY00:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"gpt_icon":0},{"id":"1111605672","title":"HKDaily Brief: Lithium Iron Phosphate Prices Surge; Tesla (TSLA.US) Hits Near One-Year High","url":"https://stock-news.laohu8.com/highlight/detail?id=1111605672","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111605672?lang=en_us&edition=fundamental","pubTime":"2025-12-16 07:58","pubTimestamp":1765843112,"startTime":"0","endTime":"0","summary":"**Key Highlights**   China National Nuclear Corporation (CNNC) has achieved a breakthrough in the full-chain technology for iodine-131 production using enriched tellurium-130 oxide targets. This...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","LU0077335932.USD","LU1629891620.HKD","BK4527","LU0320765059.SGD","LU1145028129.USD","LU1548497426.USD","IE00BK4W5M84.HKD","LU0345770308.USD","LU0943347566.SGD","LU2471134523.USD","LU2756315664.SGD","BK4511","LU0082616367.USD","LU2420271590.USD","IE00B19Z8W00.USD","BK4548","LU0823414478.USD","LU1674673691.USD","LU2602419157.SGD","LU0708995401.HKD","BK4598","LU0056508442.USD","BK4581","LU0345770993.USD","LU1861220033.SGD","LU0820561909.HKD","BK4592","LU2417539215.USD","LU1861559042.SGD","LU0109391861.USD","LU1435385759.SGD","LU0964807845.USD","LU0719512351.SGD","IE00B1BXHZ80.USD","LU2403377893.USD","LU0345769631.USD","LU2236285917.USD","BK4533","LU0820562030.AUD","LU1720051017.SGD","LU2087621335.USD","LU2456880835.USD","BK4516","LU0053666078.USD","BK4574","LU1267930730.SGD","LU2750360997.AUD","LU1720051108.HKD","LU0672654240.SGD","LU1914381329.SGD","LU1778281490.HKD","LU0689472784.USD","LU1852331112.SGD","LU2750360641.GBP","SG9999015986.USD","BK4612","LU2357305700.SGD","SG9999015978.USD","SG9999015952.SGD","TSLA","BK4550","LU1861215975.USD","SG9999015945.SGD","BK1222","LU2360107168.USD","BK4604","BK4588","LU1066051811.HKD","LU1551013342.USD","LU0097036916.USD","IE00B1XK9C88.USD","BK4534","LU2249611893.SGD","LU0316494557.USD","LU1674673428.USD","TSLL","LU1861558580.USD","01763","LU1066053197.SGD","LU0820561818.USD","TSYW.SI","IE00B19Z9505.USD","LU2290526834.HKD","LU1366192091.USD","LU2896262040.SGD","LU1839511570.USD","LU0466842654.USD","LU0345769128.USD","LU2326559502.SGD","LU2213496289.HKD","LU0210536198.USD","IE00BSNM7G36.USD","IE0034235303.USD","LU1551013425.SGD","LU0823411888.USD","LU1232071149.USD","LU1429558221.USD","LU2462157665.USD","LU2471134952.CNY","IE00B19Z8X17.USD","IE00BK4W5L77.USD","LU1066051225.USD","IE00BWXC8680.SGD","LU2756315318.SGD","LU0198837287.USD","LU2360106780.USD","LU2023250330.USD","LU0234572021.USD","BK4585","LU2108987350.USD","LU0348723411.USD","LU0234570918.USD","LU2471134879.HKD","LU1066051498.USD","LU0323591593.USD","IE00BJLML261.HKD","BK4551","LU2250418816.HKD","BK4555","BK4099","LU2471134796.USD","LU2063271972.USD"],"gpt_icon":1},{"id":"1181808812","title":"CIRC (01763) Subsidiary Atomic High-Tech Wins First Prize in Beijing Medical Science and Technology Award for Pediatric Neuroblastoma Project","url":"https://stock-news.laohu8.com/highlight/detail?id=1181808812","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181808812?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:04","pubTimestamp":1765807477,"startTime":"0","endTime":"0","summary":"CIRC (01763) announced that its subsidiary, Atomic High-Tech Co., Ltd., participated in the project \"Establishment of a Multimodal Nuclear Medicine Molecular Imaging System for Pediatric...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01763"],"gpt_icon":0},{"id":"1133966357","title":"CIRC (01763) Subsidiary Atom High-Tech Signs Commercial Cooperation Agreement with Novartis AG","url":"https://stock-news.laohu8.com/highlight/detail?id=1133966357","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133966357?lang=en_us&edition=fundamental","pubTime":"2025-12-15 21:18","pubTimestamp":1765804695,"startTime":"0","endTime":"0","summary":"CIRC (01763) announced that its subsidiary, Atom High-Tech Co., Ltd., has officially signed a commercial cooperation agreement with Novartis Pharma Tech (Zhejiang) Co., Ltd. (Novartis AG) for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","IE00B2B36J28.USD","IE0002141913.USD","BK4532","LU0070302665.USD","BK4585","BK4578","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","NVS","LU0211331839.USD","01763","IE00BJJMRZ35.SGD","BK4007","LU0208291251.USD","IE0009355771.USD","BK4588","LU0320765489.SGD"],"gpt_icon":0},{"id":"2591864924","title":"China Isotope & Radiation Corp - Agreement in Relation to Pluvicto","url":"https://stock-news.laohu8.com/highlight/detail?id=2591864924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591864924?lang=en_us&edition=fundamental","pubTime":"2025-12-15 21:13","pubTimestamp":1765804380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL02H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2591265649","title":"China Isotope & Radiation - Unit Enters Commercial Cooperation Agreement With Novartis Pharma Technology (Zhejiang)","url":"https://stock-news.laohu8.com/highlight/detail?id=2591265649","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591265649?lang=en_us&edition=fundamental","pubTime":"2025-12-15 21:13","pubTimestamp":1765804380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL02H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2591267649","title":"China Isotope & Radiation Corporation Signs Commercial Cooperation Agreement with Novartis Pharma Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2591267649","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591267649?lang=en_us&edition=fundamental","pubTime":"2025-12-15 21:12","pubTimestamp":1765804365,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation Corporation announced that its subsidiary, HTA Co., Ltd., has entered into a commercial cooperation agreement with Novartis Pharma Technology  Co., Ltd. The agreement relates to Pluvicto , with the aim of providing customized product supply and related solutions to medical institutions and patients. According to the company, Novartis and its ultimate beneficial owners are independent third parties, and the agreement does not constitute a notifiable or connected transaction under the Hong Kong Listing Rules. Shareholders and investors are advised to exercise caution when dealing in the company's securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Isotope & Radiation Corporation published the origin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL3PVbw6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01763"],"gpt_icon":0},{"id":"2590524136","title":"China Isotope & Radiation Renews Contracts With CNNC","url":"https://stock-news.laohu8.com/highlight/detail?id=2590524136","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590524136?lang=en_us&edition=fundamental","pubTime":"2025-12-12 12:01","pubTimestamp":1765512110,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation (HKG:1763) said it is renewing a range of agreements with China National Nuclear Corp., or CNNC, according to a Hong Kong bourse filing Thursday.Shares of the radiopharmaceut","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNNC","01763","BK1222"],"gpt_icon":0},{"id":"1198349769","title":"HK Stock Announcement Highlights | ZTE in Talks with U.S. DOJ Over FCPA Compliance Investigation, Vows to Defend Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=1198349769","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198349769?lang=en_us&edition=fundamental","pubTime":"2025-12-11 23:20","pubTimestamp":1765466424,"startTime":"0","endTime":"0","summary":"Key Updates:   - CiDi (03881) opens IPO from Dec 11–16, offering 5.408M H shares globally, with Xiangjiang Zhizheng as cornerstone investor.   - Smart Mining (02546) launches IPO Dec 11–16, issuing...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYTNYN87.SGD","BK1149","BK1530","BK1526","LU2045819591.USD","LU0572944931.SGD","LU1580142542.USD","LU2242644610.SGD","IE0008368742.USD","SG9999001689.USD","BK0183","LU2148510915.USD","LU0327786744.USD","LU2328871848.SGD","LU1328615791.USD","BK0055","BK1607","BK1125","BK0188","BK0103","BK0167","LU2125910500.SGD","LU0543330566.HKD","LU1102505762.USD","IE0031814852.USD","LU0084288322.USD","01763","LU0229945570.USD","BK0030","BK1524","LU0149534421.HKD","SG9999011746.SGD","LU1781817850.SGD","00836","BK1529","BK0018","IE0009570106.USD","BK0028","BK0123","BK1183","LU1064131003.USD","01811","000063","LU0607220059.USD","BK0058","BK0171","09863","00763","LU0227179875.USD","IE0034224299.USD","LU1969619763.USD","IE0008369823.USD","00669","BK1222","BK0090","BK0000","LU0048388663.USD","BK0026","IE00B031HY20.USD","BK0148","02670","BK1570","IE00B031HW06.USD","BK1521","BK0196","BK1119","SG9999000327.SGD","BK0012","BK1594","IE00B0169N27.USD","BK0067","BK1506","BK0214","LU0106259558.USD","LU2177674079.SGD","BK0125","IE00BYQNZ168.SGD","LU2039709279.SGD","IE00B12V2V27.USD","IE00B031J352.USD","LU2008162690.USD","LU1064130708.USD","IE0008368411.USD"],"gpt_icon":1},{"id":"1197790463","title":"CIRC (01763): Subsidiary Signs Patent Transfer Agreement and Industry-University-Research Collaboration for Innovative Nuclear Drug Fluorine [18F] Betazine","url":"https://stock-news.laohu8.com/highlight/detail?id=1197790463","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197790463?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:46","pubTimestamp":1765460776,"startTime":"0","endTime":"0","summary":"CIRC (01763) announced that on December 10, 2025, its subsidiary Atom HighTech Co., Ltd., listed on the National Equities Exchange and Quotations, signed a patent transfer agreement and an...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2590435364","title":"China Isotope & Radiation Corporation (HKG:1763) Investors Are Less Pessimistic Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2590435364","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590435364?lang=en_us&edition=fundamental","pubTime":"2025-12-09 06:28","pubTimestamp":1765232893,"startTime":"0","endTime":"0","summary":"It's not a stretch to say that China Isotope & Radiation Corporation's ( HKG:1763 ) price-to-earnings (or \"P/E\") ratio...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1763/china-isotope-radiation-shares/news/china-isotope-radiation-corporation-hkg1763-investors-are-le","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1763/china-isotope-radiation-shares/news/china-isotope-radiation-corporation-hkg1763-investors-are-le","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","ISBC","BK1222","01763"],"gpt_icon":0},{"id":"1144481562","title":"China Isotope & Radiation Corporation (01763) Announces Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1144481562","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144481562?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:07","pubTimestamp":1764580024,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation Corporation published its monthly return for equity issuers, confirming that for the month ended 30 November 2025, there were no changes in its issued or treasury shares....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"gpt_icon":0},{"id":"1160892719","title":"CIRC (1763) and CNNC Capital Sign Strategic Cooperation Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1160892719","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160892719?lang=en_us&edition=fundamental","pubTime":"2025-11-27 12:21","pubTimestamp":1764217290,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation Corporation (CIRC, Stock Code: 1763) and CNNC Capital Holdings Limited entered into a strategic cooperation agreement on November 27, during the Second Nuclear Technology...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"gpt_icon":0},{"id":"1163055623","title":"CIRC (01763) Signs Strategic Cooperation Agreement with CNNC Capital to Drive High-Quality Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1163055623","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163055623?lang=en_us&edition=fundamental","pubTime":"2025-11-27 12:06","pubTimestamp":1764216393,"startTime":"0","endTime":"0","summary":"On November 27, CIRC (01763) announced the signing of a Strategic Cooperation Agreement with China National Nuclear Corporation Capital Holdings Co., Ltd. (CNNC Capital) during the Second Nuclear...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2586921308","title":"China Isotope & Radiation Corporation and CNNC Capital Sign Strategic Cooperation Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2586921308","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586921308?lang=en_us&edition=fundamental","pubTime":"2025-11-27 12:02","pubTimestamp":1764216130,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation Corporation  has entered into a strategic cooperation agreement with CNNC Capital Holdings Limited. The partnership aims to promote the integration of the nuclear technology application industry chain, address key technology bottlenecks, and cultivate new quality productive forces. Both parties will collaborate through resource sharing, mergers and acquisitions, company establishment, equity investment, and securities business. The cooperation is designed to establish a new model of synergistic development between technology and finance, as well as industry and finance, to support CIRC's high-quality development with enhanced financial capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Isotope & Rad","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nNDL2f98TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"gpt_icon":0},{"id":"2586213797","title":"China Isotope & Radiation - Co and CNNC to Collaborate in M&a and Equity Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2586213797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586213797?lang=en_us&edition=fundamental","pubTime":"2025-11-27 12:01","pubTimestamp":1764216087,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nFWN3X213D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01763","BK1222"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-isotope.com","stockEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.3333},{"period":"6month","weight":0.3794},{"period":"1year","weight":1.0614},{"period":"ytd","weight":0.9855}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.02846},{"month":2,"riseRate":0.571429,"avgChangeRate":0.052162},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.034143},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.013249},{"month":5,"riseRate":0.571429,"avgChangeRate":0.015374},{"month":6,"riseRate":0.571429,"avgChangeRate":0.05564},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.022851},{"month":8,"riseRate":0.5,"avgChangeRate":0.038573},{"month":9,"riseRate":0.125,"avgChangeRate":-0.029064},{"month":10,"riseRate":0.625,"avgChangeRate":-0.037438},{"month":11,"riseRate":0.75,"avgChangeRate":0.064344},{"month":12,"riseRate":0.5,"avgChangeRate":0.005076}],"exchange":"SEHK","name":"CIRC","nameEN":"CIRC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CIRC(01763),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CIRC(01763) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CIRC,01763,CIRC股票,CIRC股票老虎,CIRC股票老虎国际,CIRC行情,CIRC股票行情,CIRC股价,CIRC股市,CIRC股票价格,CIRC股票交易,CIRC股票购买,CIRC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CIRC(01763),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CIRC(01763) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}